Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NASDAQ NASDAQ · AMGN

Amgen

$364.17 -$2.11 -0.58% CLOSE 07.20.26 AFTER HOURS $363.59
Convergence score
3.6 / 5.0 BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$356.62 -2.1%
Range $200.00 — $427.00
Sector
Health Care
NASDAQ · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
3.6
/ 5.0
BULLISH
Consensus signal A
4.0
Consensus signal B
3.0
Consensus signal D
4.0
Rating trend signal
3.7
Analyst average
3.6
Multi-signal aggregate How CSR works →
Day Range
$363.65 – $370.29
52W Range
$269.77 – $391.29
Volume
1.7M
Avg Vol
2.7M
Mkt Cap
$196.55B
P/E
25.36
EPS (TTM)
$14.36
Div Yield
2.75%
Beta
0.40
Today's convergence

Convergence score sits at 3.6 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
BULLISH
Last close
$364.17
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$357-2.1% Hold
Long term
12–36 MO
$299.01-17.9% Overvalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$356.62 -2.1%
RANGE $200.00 — $427.00
Analyst consensus
Consensus rating Buy
Blended score 3.6 / 5
Analysts tracked 128
Open analysts →
Financials
Key metrics
LATEST
P/E
25.36
EPS (TTM)
$14.36
Mkt Cap
$196.55B
Div Yield
2.75%
Beta
0.40
52W Range
$269.77 – $391.29
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Hold
Consensus target
$357 -2.1%
RANGE $200 – $427
$200NOW $364.17$427

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$299.01 -17.9%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 25.36PEG Ratio: -DE Ratio: -
Free Cash Flow: $7.44BPB Ratio: -PS Ratio: -Dividend: $2.52
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 3.6 4 128
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $200.00 $356.62 $355.00 $427.00 -2.1%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 6 21 32 4 1
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Moderate Buy 3.66 35
1 Mo Ago Moderate Buy 3.64 36
2 Mo Ago Moderate Buy 3.64 36
3 Mo Ago Moderate Buy 3.66 35
Most recent analyst action LATEST DESK ACTION
Date
7/15/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Buy (B) ➝ Buy (B-)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$366.29
Open
$367.95
Day Low
$363.65
Day High
$370.29
Bid
$365.35
Ask
$366.31
52W Low
$269.77
52W High
$391.29
50D Avg
$346.50
200D Avg
$339.65
Volume
1.7M
Avg Vol
2.7M
10D Avg Vol
2.1M
52W Change
23.80%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
25.36
P/E (Fwd)
15.53
PEG (Fwd)
2.01
P/S
5.28
P/B
21.39
Book Value
$17.03
EV/Revenue
6.50
EV/EBITDA
14.29
Mkt Cap
196.55B
Enterprise Val
241.83B
Profitability & returns 6 FIELDS
Profit Margin
20.96%
Gross Margin
71.44%
Operating Margin
33.80%
EBITDA Margin
45.45%
Return on Assets
8.35%
Return on Equity
101.32%
Growth 3 FIELDS
Revenue Growth (YoY)
5.80%
Earnings Growth (YoY)
4.40%
Earnings Growth (Q)
5.10%
Balance sheet & cash flow 11 FIELDS
Total Revenue
37.22B
EBITDA
16.92B
Total Cash
12.04B
Total Debt
57.32B
Cash / Share
$22.30
Revenue / Share
$69.12
Free Cash Flow
7.44B
Operating CF
10.76B
Debt / Equity
623.75
Current Ratio
1.26
Quick Ratio
0.85
Dividend 5 FIELDS
Fwd Dividend
10.08 (2.75%)
Dividend Yield
2.75%
Payout Ratio
67.22%
5Y Avg Yield
3.07%
Ex-Div Date
2026-05-15
Share statistics 7 FIELDS
Shares Out
539.71M
Float
538.22M
Shares Short
12.87M
% Short of Float
2.39%
Short Ratio
4.09
% Held Insiders
0.22%
% Held Institutions
86.51%
Calendar & events 5 FIELDS
Next Earnings
2026-08-04
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-03-31
Last Split
2:1
Split Date
1999-11-22
Company 2 FIELDS
Industry
Drug Manufacturers - General
Employees
31,500